SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Reents Scott T – ‘3’ for 6/28/22 re: AbbVie Inc. – ‘EX-24’

On:  Friday, 7/8/22, at 1:11pm ET   ·   For:  6/28/22   ·   As:  Officer   ·   Accession #:  1415889-22-7553   ·   File #:  1-35565

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/08/22  Reents Scott T                    3          Officer     2:14K  AbbVie Inc.                       SEC Connect

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of        HTML     11K 
                Securities by an Insider --                                      
                form3-07082022_100701.xml/2.6                                    
 2: EX-24       Power of Attorney                                   HTML      7K 


‘EX-24’   —   Power of Attorney


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 24

 

POWER OF ATTORNEY

 

The undersigned constitutes and appoints LAURA J. SCHUMACHER, JENNIFER M. LAGUNAS, STEVEN L. SCROGHAM, and TOLANI O. ODUTAYO, and each of them individually, as the undersigned's true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for the undersigned and in the undersigned's name, place and stead, to prepare and sign any and all Securities and Exchange Commission ("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144 under the Securities Act of 1933 on Form 144, all SEC statements on Forms 3, 4 and 5 as required under Section 16(a) of the Securities Exchange Act of 1934, including a Form ID and any other documents necessary to obtain codes and passwords necessary to make electronic filings, and any amendments or successors to such forms, and to file the same with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite, necessary or desirable to be done under said Rule 144 and Section 16(a), as fully for all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.

 

A copy of this power of attorney shall be filed with the SEC. The authorization set forth above shall continue in full force and effect until the undersigned is no longer required to file Forms 144, 3, 4, or 5 or if earlier, until the undersigned revokes such authorization by written instructions to the attorney-in-fact.

 

Date: June 15, 2022  
   
/s/ Scott T. Reents  
Signature of Reporting Person  
   
Scott T. Reents  
Name  
   
AbbVie Inc.  
1 N. Waukegan Road  
North ChicagoIL 60064  

 

 C: 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘3’ Filing    Date    Other Filings
Filed on:7/8/22
For Period end:6/28/228-K
6/15/22
 List all Filings 
Top
Filing Submission 0001415889-22-007553   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 7:04:28.1pm ET